Clinical Improvement After Treatment With IncobotulinumtoxinA (XEOMIN®) in Patients With Cervical Dystonia Resistant to Botulinum Toxin Preparations Containing Complexing Proteins

Clinical Improvement After Treatment With IncobotulinumtoxinA (XEOMIN®) in Patients With Cervical Dystonia Resistant to Botulinum Toxin Preparations Containing Complexing Proteins

This study investigated the clinical long-term effect of incobotulinumtoxinA (incoBoNT/A) in 33 cervical dystonia (CD) patients who had developed partial secondary therapy failure (PSTF) under previous long-term botulinum toxin (BoNT) treatment. Patients were treated four times every 12 weeks with i...

Full description

Bibliographic Details
Main Authors: Harald Hefter, Christian J. Hartmann, Ulrike Kahlen, Sara Samadzadeh, Dietmar Rosenthal, Marek Moll
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Neurology
Subjects:
incobotulinumtoxinA
cervical dystonia
complexing proteins
partial secondary therapy failure
neutralizing antibodies
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.636590/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2021.636590/full

Similar Items